We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 102.00
Bid: 102.00
Ask: 102.40
Change: -0.80 (-0.78%)
Spread: 0.40 (0.392%)
Open: 104.60
High: 105.20
Low: 102.00
Prev. Close: 102.80
PZC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed sale of Minerva and Luksja brand

29 Aug 2019 07:00

RNS Number : 4838K
PZ CUSSONS PLC
29 August 2019
 

PZ Cussons

 

("PZ Cussons" or the "Group")

 

Proposed sale of Minerva and Luksja brand

 

 

PZ Cussons Plc, a leading international consumer products group, is pleased to announce that, in line with the Company's newly stated strategic direction, it has entered into agreements to sell its Greek food subsidiary Minerva and its Polish personal care brand Luksja.

 

Sale of Minerva

 

PZ Cussons has exchanged contracts for the sale of 100% of the share capital of its Greek subsidiary, Minerva S.A. Edible Oils and Food Enterprises ("Minerva") to Mirties Enterprises Company Limited, a company controlled by Diorama Investments SICAR SA ("Diorama"), a Luxembourg investment company, regulated by Luxembourg's Capital Markets Commission. Diorama has appointed Deca Investments AIFM ("Deca") as its external fund manager.

 

Minerva is being sold for a consideration of £41.0 million1 in cash, payable upon completion. Completion will occur upon draw down of funds by the purchaser from its financing bank which is expected within the next few weeks. The proceeds from the sale will be used to reduce existing debt in the business and drive focused investment in our core brands as part of the Group's new strategy to 'Focus, Scale and Accelerate'.

 

Founded in 1904, Minerva was the first company to sell branded packaged olive oil in Greece. Over a rich history spanning more than 115 years, Minerva has established itself as an iconic brand and holds leading positions in each of the olive oil, spreads, vinegar and cheese categories. Minerva's products are marketed under 10 well-known brands and the business has export activities across a number of countries.

 

The profits and gross assets attributable to Minerva are £0.5m2 and £53.6m3 respectively, as disclosed in Minerva's latest published local accounts for the 2018 financial year. PZ Cussons' results for the year ended 31 May 2019 included Minerva Sales and EBITDA of £44.1m and £3.3m respectively. The sale of Minerva would reduce the Group's FY19 PBT by c.£1.8m on a pro forma basis.

 

The sale of Minerva constitutes a class 2 transaction for the purposes of the UK Listing Rules. A further announcement regarding completion of the transaction will be made at the appropriate time.

 

Sale of Luksja

 

On 12 August, PZ Cussons also exchanged contracts for the sale of Polish personal care brand, Luksja, together with all associated inventory, to Athens based personal care company, Sarantis Group ("Sarantis"). PZ Cussons and Sarantis have also agreed to enter into a distribution agreement whereby Sarantis will distribute certain PZ Cussons' core brands (which include Carex, Original Source and Morning Fresh) in Poland and Central and Eastern Europe.

 

Completion of the transaction and commencement of the distribution agreement is subject to competition clearance being granted in relevant territories, including Poland. Following completion, PZ Cussons' on-the-ground operations in Poland will be wound down.

 

 

Alex Kanellis, CEO of PZ Cussons said:

 

"The proposed sale of Minerva and Luksja forms part of PZ Cussons' new strategy to 'Focus, Scale and Accelerate', announced along with our final FY19 results on 23 July 2019. We are streamlining the Group to focus investment on core Personal Care and Beauty brands to deliver higher margin earnings, in geographies that can scale, with the aim of returning the Group to sustainable, profitable growth. 

 

The sale of Minerva provides additional proceeds to continue to drive our strategy forward. Deca is an excellent partner for Minerva's future growth prospects and I would like to thank the Minerva team for their hard work and dedication during their time with us and wish them every success in the future.

 

Luksja is a great fit with Sarantis's portfolio and I would like to thank the Luksja team for their important contribution to the development of PZ Cussons Poland in recent years."

 

- Ends -

 

Press enquiries

 

PZ Cussons

Alan Bergin (Interim Chief Financial Officer)

 

0161 435 1236

Instinctif

Tim Linacre / Guy Scarborough

020 7457 2020

 

 

Notes

 

1 Consideration translated from EUR to GBP at spot rate on 28 August of 1.10

2 Profits the subject of the transaction translated from EUR to GBP at the average rate between 01/06/2017 and 31/05/2018 of 1.1290

3 Gross Assets the subject of the transaction translated from EUR into GBP at the closing rate at 31/05/2018 of 1.1399

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCXVLLLKVFBBBL
Date   Source Headline
20th Dec 20222:40 pmRNSDirector/PDMR Shareholding
2nd Dec 202212:55 pmRNSDirector/PDMR Shareholding
24th Nov 20223:24 pmRNSResult of AGM
24th Nov 20227:00 amRNSDirectorate Change
21st Nov 20223:21 pmRNSDirector/PDMR Shareholding
14th Nov 20227:00 amRNSNew Credit Facility Linked to B Corp Ambitions
18th Oct 20223:52 pmRNSDirector/PDMR Shareholding
14th Oct 20227:00 amRNSPublication of Annual Report and Notice of AGM
27th Sep 202210:52 amRNSDirector/PDMR Shareholding
23rd Sep 20223:04 pmRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNS2022 Full Year Results
21st Sep 202210:06 amRNSDirector Declaration
2nd Sep 202210:29 amRNSHolding(s) in Company
19th Aug 202210:05 amRNSDirector/PDMR Shareholding
29th Jul 20229:46 amRNSDirector/PDMR Shareholding
20th Jul 20223:21 pmRNSDirector/PDMR Shareholding
27th Jun 20227:00 amRNSTrading update
21st Jun 20224:10 pmRNSDirector/PDMR Shareholding
20th May 202210:30 amRNSFurther re 2021 AGM voting results
19th May 20225:45 pmRNSDirector/PDMR Shareholding
21st Apr 202210:30 amRNSDirector/PDMR Shareholding
13th Apr 20227:00 amRNSTrading Statement
1st Apr 20229:00 amRNSDirector/PDMR Shareholding
25th Mar 202210:00 amRNSDirector/PDMR Shareholding
23rd Mar 20229:00 amRNSDirector/PDMR Shareholding
21st Mar 202210:15 amRNSDirector/PDMR Shareholding
21st Mar 20227:00 amRNSAcquisition of Childs Farm
21st Feb 202211:00 amRNSDirector/PDMR Shareholding
11th Feb 20229:25 amRNSDirector/PDMR Shareholding
11th Feb 20229:15 amRNSBoard update
9th Feb 20227:00 amRNSHalf-year Report
19th Jan 202210:10 amRNSDirector/PDMR Shareholding
20th Dec 20214:35 pmRNSDirector/PDMR Shareholding
9th Dec 20219:38 amRNSNotice of Interim Results
29th Nov 202111:25 amRNSDirector/PDMR Shareholding
25th Nov 20214:40 pmRNSDirector/PDMR Shareholding
23rd Nov 20214:05 pmRNSAnnual General Meeting
9th Nov 20217:00 amRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSPublication of Annual Report and notice of AGM
24th Sep 20219:00 amRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading Statement
22nd Sep 20217:00 amRNSFinal Results
13th Sep 20213:00 pmRNSAppointment of Non Executive Director
27th Jul 202111:00 amRNSDirector/PDMR Shareholding
5th Jul 20214:00 pmRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSTrading update
29th Jun 202110:45 amRNSNotice of pre-close trading update
25th Jun 20217:00 amRNSAppointment of Non Executive Director
27th Apr 20217:00 amRNSTrading Statement
25th Mar 20217:00 amRNSCapital Markets Day

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.